Comparison study of the efficacy of HA330 and HA380 perfusion devices in severe acute pancreatitis with hypertriglyceridemia.

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500108836

Enrollment

Unknown

Registered

2025-09-08

Start date

2025-07-01

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertriglyceridemia severe acute pancreatitis

Interventions

HA330 Group:NA

HA380 Group:NA

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meeting diagnostic criteria for hyperlipidemic acute pancreatitis; 2. Meeting SAP diagnostic criteria; 3. Admitted to hospital within 48 hours of onset; 4. Those who underwent hemoperfusion therapy after admission; 5. The age of the patient is between 18~80 years old.

Exclusion criteria

Exclusion criteria: 1. Other causes of acute pancreatitis, such as cholelithiasis and alcoholism, are excluded; 2. Pregnant or lactating women; 3. The length of hospital stay < 7 days; 4. Clinical data were incomplete.

Design outcomes

Primary

Measure	Time frame
triglycerides;hypersensitive C-reactive protein;procalcitonin;	—

Secondary

Measure	Time frame
abdominal infection;hospital day;abdominal compartment syndrome;hospitalization cost;hemoglobin;platelet;shock;acute respiratory distress syndrome;white blood cell count;ICU hospitalization period;	—

Countries

China

Contacts

Public ContactYe Ying

The Affiliated Hospital of Xuzhou Medical University

xzmcyy@163.co+86 180 5226 8313

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026